Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|August 11, 2010
Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapyPhuong K Morrow, Stephen Divers, Louise Provencher, et al.
Therapeutic Innovation & Regulatory Science|June 18, 2019
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
Therapeutic Innovation & Regulatory Science|December 10, 2020
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case StudiesChristoph Muysers, Alex Dmitrienko, Hermann Kulmann, et al.
Retina (Philadelphia, Pa.)|March 2, 2022
INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized TrialDavid M Brown, David S Boyer, Karl Csaky, et al.
The Oncologist|October 10, 2013
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathyMario Campone, Dominique Berton-Rigaud, Florence Joly-Lobbedez, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized TrialJeffrey S Heier, Allen C Ho, David S Boyer, et al.
Ophthalmology|April 28, 2012
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edemaDiana V Do, Quan Dong Nguyen, David Boyer, et al.
JAMA Ophthalmology|December 23, 2016
Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema: Subanalysis of the VISTA and VIVID Randomized Clinical TrialsCharles C Wykoff, Dennis M Marcus, Edoardo Midena, et al.
British Journal of Clinical Pharmacology|October 21, 2018
The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trialAntonia M Joussen, Sebastian Wolf, Peter K Kaiser, et al.
Ophthalmology|December 4, 2019
Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA TrialJeffrey S Heier, Charles C Wykoff, Nadia K Waheed, et al.
Pageof 5